Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma

被引：0
|
作者：
Astuti, Dewi [1 ]
Ricketts, C. [1 ]
Chowdury, R. [2 ]
McDonough, M. A. [2 ]
Gentle, D. [1 ]
Kirby, G. [1 ]
Schlisio, S. [3 ]
Racliffe, P.
Schofield, C. J. [2 ]
Latif, F. [1 ]
Maher, E. R. [1 ,4 ]
机构：
[1] Univ Birmingham, Coll Med & Dent Sci, Ctr Rare Dis & Personalised Med,Inst Biomed Res, Dept Med & Mol Genet,Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
[2] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 2JD, England
[3] Karolinska Inst, Ludwig Inst Canc Res Ltd, Oxygen Sensing & Canc Lab, Stockholm, Sweden
[4] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England
来源：
JOURNAL OF MEDICAL GENETICS | 2010年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [1] Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility
    Astuti, Dewi
    Ricketts, Christopher J.
    Chowdhury, Rasheduzzaman
    McDonough, Michael A.
    Gentle, Dean
    Kirby, Gail
    Schlisio, Susanne
    Kenchappa, Rajappa S.
    Carter, Bruce D.
    Kaelin, William G., Jr.
    Ratcliffe, Peter J.
    Schofield, Christopher J.
    Latif, Farida
    Maher, Eamonn R.
    [J]. ENDOCRINE-RELATED CANCER, 2011, 18 (01) : 73 - 83
  • [2] Analysis of HIF-prolyl hydroxylases binding to substrates
    Landazuri, Manuel O.
    Vara-Vega, Alicia
    Viton, Mariano
    Cuevas, Yolanda
    del Peso, Luis
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (02) : 313 - 320
  • [3] Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma
    Luomala, Lassi
    Mattila, Kalle
    Vainio, Paula
    Nisen, Harry
    Pellinen, Teijo
    Lohi, Jouni
    Laajala, Teemu D.
    Jarvinen, Petrus
    Koskenniemi, Anna-Riina
    Jaakkola, Panu
    Mirtti, Tuomas
    [J]. CANCER MEDICINE, 2024, 13 (03):
  • [4] HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
    Miikkulainen, Petra
    Hogel, Heidi
    Rantanen, Krista
    Suomi, Tomi
    Kouvonen, Petri
    Elo, Laura L.
    Jaakkola, Panu M.
    [J]. CANCER & METABOLISM, 2017, 5
  • [5] HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
    Petra Miikkulainen
    Heidi Högel
    Krista Rantanen
    Tomi Suomi
    Petri Kouvonen
    Laura L. Elo
    Panu M. Jaakkola
    [J]. Cancer & Metabolism, 5
  • [6] Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation
    Sangkhathat, S
    Kusafuka, T
    Yoneda, A
    Kuroda, S
    Tanaka, M
    Sakai, N
    Fukuzawa, M
    [J]. PEDIATRIC SURGERY INTERNATIONAL, 2005, 21 (09) : 745 - 748
  • [7] Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation
    Surasak Sangkhathat
    Takeshi Kusafuka
    Akihiro Yoneda
    Seika Kuroda
    Mio Tanaka
    Norio Sakai
    Masahiro Fukuzawa
    [J]. Pediatric Surgery International, 2005, 21 : 745 - 748
  • [8] Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation
    Surasak Sangkhathat
    Takeshi Kusafuka
    Akihiro Yoneda
    Seika Kuroda
    Yukichi Tanaka
    Norio Sakai
    Masahiro Fukuzawa
    [J]. Pediatric Surgery International, 2006, 22 (2) : 207 - 207
  • [9] Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma
    Miikkulainen, Petra
    Hogel, Heidi
    Seyednasrollah, Fatemeh
    Rantanen, Krista
    Elo, Laura L.
    Jaakkola, Panu M.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (10) : 3760 - 3771
  • [10] Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinoma
    Kaufmann, Muriel R.
    Schraml, Peter
    Hermanns, Thomas
    Wenger, Roland H.
    Camenisch, Gieri
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (03) : 453 - 457
12345